Coderio

At Septeo, we believe that meaningful software is built by people who truly understand the professionals they serve. Our team of over 300 engineers works daily to enhance solutions that support legal experts, real estate professionals, hospitality managers, HR directors, accountants, and educators. We don't just write code - we immerse ourselves in our clients' worlds, maintaining close relationships that help us anticipate industry changes in real time. This 'Customer Lover' mindset isn't just a label; it's the foundation of how we collaborate, communicate, and build products that genuinely matter. Our culture thrives on three core principles: being together in simplicity and fellowship, doing together with confidence and team spirit, and transforming together with commitment and agility. Every day, more than 3,600 Septeo team members across 10+ countries embody these values, whether they're engineering AI-powered solutions in our BRAIN lab, supporting clients through complex transitions, or gathering at company events to celebrate shared achievements. We've invested €80 million in R&D with a sharp focus on integrating generative AI throughout our offerings - because we believe innovation happens when curious, bold people collaborate freely and push boundaries together.

Clario is a leading healthcare research and technology company that generates high-quality clinical evidence for pharmaceutical, biotechnology, and medical device partners. Formerly known as ERT and Bioclinica, Clario brings over 50 years of expertise to clinical trial management. The company fuses deep scientific knowledge with global scale to deliver the broadest endpoint technology platform available. Clario has supported nearly 900 regulatory approvals across 19,000 studies spanning almost 600 indications, demonstrating a proven track record of accelerating drug development and reducing trial risk. Clario's comprehensive solutions span cardiac safety, electronic clinical outcome assessments (eCOA), medical imaging, precision motion, respiratory endpoints, and clinical adjudication. The company supports decentralized, hybrid, and site-based trials with advanced cloud-native technologies and AI-powered tools. With a presence in more than 80,000 sites worldwide, Clario's science-informed approach ensures the richest evidence possible for life-changing therapies. Their mission is to transform lives by unlocking better evidence, uniting clinical science, innovative technology, and global expertise to bring new treatments to patients faster.

Twilio was founded in 2008 to simplify the complexity of the global telecommunications network and bring communications to the cloud. Every day, millions of developers and over 335,000 businesses use Twilio to create personalized, engaging customer experiences across every channel. Twilio exists to democratize access to powerful communication tools that were once the exclusive domain of telecom giants - giving businesses the APIs to add SMS, voice, WhatsApp, video, and email directly into their applications. As the customer engagement platform that uniquely combines communications APIs with first-party data and artificial intelligence, Twilio helps companies build trusted, durable relationships through personalized interactions at scale. From fraud prevention and user verification to marketing campaigns and contact centers, Twilio provides the building blocks for modern customer communication. Named a Leader in the 2025 Gartner Magic Quadrant for CPaaS and positioned highest for Ability to Execute, Twilio continues to innovate at the intersection of data, AI, and customer experience.

DNAnexus is the enterprise platform for precision health, transforming how genomic and multiomic data is managed, analyzed, and shared across the healthcare and life sciences industries. Founded in 2009 and building on 15 years of bioinformatics innovation, the company provides a secure, cloud-based platform that centralizes complex biological datasets and enables collaborative research at unprecedented scale. Trusted by leading pharmaceutical companies, academic medical centers, clinical diagnostic labs, and biobanks worldwide, DNAnexus processes petabytes of precision health data to accelerate scientific discovery and improve patient outcomes. The platform delivers comprehensive capabilities for ingesting, organizing, and analyzing multimodal data - from next-generation sequencing to real-world evidence - while maintaining clinical-grade security and compliance. DNAnexus powers the world's largest genomics initiatives, including partnerships with major biobanks and research consortia, enabling breakthroughs in drug development, precision medicine, and population health. By combining cloud computing infrastructure with deep domain expertise in computational biology, DNAnexus has established itself as the foundational technology layer for the precision health ecosystem, helping organizations translate vast biological datasets into actionable insights that advance human health.

At VELAIO, we believe that exceptional software starts with exceptional people. Founded in 2010 as a software factory, we've completed over a thousand projects by building teams that combine deep technical expertise with collaborative, problem-solving mindsets. Our developers aren't just coders - they're partners who understand the business impact of every line of code they write. We specialize in nearshore staff augmentation, connecting Latin American tech talent with companies across the United States, Canada, and LATAM. Our culture is built on trust, transparency, and tangible results. Whether delivering custom software development, dedicated agile teams, or comprehensive outsourcing solutions, we bring over 13 years of experience to every engagement. Our teams work with modern stacks including Java, .NET, Angular, React, AWS, and Azure, but what truly sets us apart is how we work - adapting to your processes, communicating proactively, and taking real ownership of outcomes. We're not just vendors; we're an extension of your team, committed to making your projects successful through technical excellence and genuine partnership.

In 2015, researchers at the University of Michigan realized something critical: security professionals, government agencies, and organizations worldwide lacked a comprehensive, trustworthy way to understand the global Internet landscape. Traditional tools provided fragmented, outdated views of Internet infrastructure, leaving organizations vulnerable to emerging threats and nation-state attacks. So they built Censys - a platform designed to be the authoritative map of the Internet, delivering real-time intelligence through continuous, comprehensive scanning. What started as an academic research project has evolved into an essential platform trusted by over half of the Fortune 500, numerous government agencies, and customers across more than fourteen countries. Censys maintains the industry's most accurate and up-to-date map of Internet infrastructure by conducting daily ZMap scans across the entire IPv4 address space and synchronizing with public certificate transparency logs. The platform enables security teams to discover devices, monitor attack surfaces, hunt for threats, and respond to emerging risks with unprecedented speed and precision. By democratizing access to Internet-scale data, Censys empowers organizations to shift from reactive to proactive security postures, helping them prevent attacks before they happen. From critical infrastructure protection to threat hunting and exposure management, Censys continues to push the boundaries of what's possible in Internet intelligence, ensuring that security teams have the visibility they need to defend their digital assets in an increasingly complex and hostile Internet environment.